Xvivo Perfusion AB (0RKL.LSE) Q3 2025 Earnings

11JulConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.38
0.7
1.77
2.85

Details

Expected EPS
0.6207026660553601
Actual EPS
0.050281392
Surprise EPS
-0.57
Surprise Percent
+91.9%

Description

Xvivo Perfusion AB (0RKL.LSE) has reported earnings of 0.050281392 per share for Q3 2025.

0 Comments

Share your thoughts